A newly approved drug is showing promise as a treatment for Lymphoma. The newly approved drug, Adceteris, brought two people together for the first time. The doctor who helped design it 20 years ago, and a patient whose life is being saved right now. "I don't have fevers I don't have tumors actual tumors in my body. I don't feel lumps anymore," said Archie McNealy.
This was Archie McNealy's PET scan in January before he started the new treatment for Hodgkins Lymphoma. The black spots are all tumors. "After 7 or 8 treatments we barely saw any evidence of malignancy," said Dr. Joseph Rosenblatt. The yellow circle on this scan is a tumor under Archie's arm. By July it was gone. "To be able to do that and have this kind of success with a drug whose origin is actually in research done I tumor immunology at this center was a particularly wonderful experience," said Dr. Rosenblatt.
Dr. Eckhard Podack developed an antibody that targets a protein found on specific cancer cells. "This molecule is present in Hodgkins lymphoma and a few other lymphomas," said Dr. Podack. Seattle Genetics combined it with a powerful chemo the antibody delivers directly to the cancer cells. "This is the first one that has brought me as close to remission as possible so I'm happy," said Archie.
Doctors are hoping to start clinical trials to test how this drug does earlier in the disease process. But for regular patients... now that it's FDA approved... the cost per dose is between nine thousand to thirteen thousand dollars.
All content © Copyright 2000 - 2014 WorldNow and KTIV Television Inc. All Rights Reserved.
Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Kathy Clayton at (712) 239-4100 x209. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at firstname.lastname@example.org.